pcDNA3.1-GGamma9-GFP2 Citations (3)

Originally described in: TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome.
Olsen RHJ, DiBerto JF, English JG, Glaudin AM, Krumm BE, Slocum ST, Che T, Gavin AC, McCorvy JD, Roth BL, Strachan RT Nat Chem Biol. 2020 May 4. pii: 10.1038/s41589-020-0535-8. doi: 10.1038/s41589-020-0535-8. PubMed Journal

---

Articles Citing pcDNA3.1-GGamma9-GFP2

Articles
A non-hallucinogenic LSD analog with therapeutic potential for mood disorders. Lewis V, Bonniwell EM, Lanham JK, Ghaffari A, Sheshbaradaran H, Cao AB, Calkins MM, Bautista-Carro MA, Arsenault E, Telfer A, Taghavi-Abkuh FF, Malcolm NJ, El Sayegh F, Abizaid A, Schmid Y, Morton K, Halberstadt AL, Aguilar-Valles A, McCorvy JD. Cell Rep. 2023 Mar 28;42(3):112203. doi: 10.1016/j.celrep.2023.112203. Epub 2023 Mar 6. PubMed
A quantitative pharmacology model for cannabinoid CB(1) receptor mediated by Gi/Gs protein competition. Yang L, Finlay DB, Green HM, Zhu X, Glass M, Duffull S. Br J Pharmacol. 2024 Apr;181(8):1324-1340. doi: 10.1111/bph.16293. Epub 2024 Jan 12. PubMed
Nanobody-Mediated Dualsteric Engagement of the Angiotensin Receptor Broadens Biased Ligand Pharmacology. Braga Emidio N, Small BM, Keller AR, Cheloha RW, Wingler LM. Mol Pharmacol. 2024 Feb 15;105(3):260-271. doi: 10.1124/molpharm.123.000797. PubMed

If you have published an article using this material, please email us at to have your article added to this page.